483
NuCare Pharmaceuticals IncFDA 483 - NuCare Pharmaceuticals Inc - January 10, 2020
Record Details
NuCare Pharmaceuticals Inc in Orange, CA, was cited for issues related to drug product stability and expiration dating during repackaging operations. The firm failed to conduct stability studies for drug products repackaged without desiccants, yet assigned them the original expiration dates. This raises concerns about the quality and purity of the products over time.
Open in Dashboard
ID · 86109b8c-2ba3-47fc-9824-cf956c6bf2dc